Literature DB >> 19278955

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.

David-Alexandre Trégouët1, Simon Heath, Noémie Saut, Christine Biron-Andreani, Jean-François Schved, Gilles Pernod, Pilar Galan, Ludovic Drouet, Diana Zelenika, Irène Juhan-Vague, Marie-Christine Alessi, Laurence Tiret, Mark Lathrop, Joseph Emmerich, Pierre-Emmanuel Morange.   

Abstract

Venous thromboembolism (VTE) is a complex disease that has a major genetic component of risk. To identify genetic factors that may modify the risk of VTE, we conducted a genome-wide association study by analyzing approximately 317 000 single nucleotide polymorphisms (SNPs) in 453 VTE cases and 1327 controls. Only 3 SNPs located in the FV and ABO blood group genes were found associated with VTE at a genome-wide significant level of 1.7 x 10(-7). Detailed analysis of these SNPs in additional cohorts of more than 1700 cases and 1400 controls revealed that the association observed at the FV locus was the result of the increased risk mediated by the FV Leiden mutation, whereas O and A2 blood groups were found to be at lower risk for VTE. Apart from the FV and ABO loci, no other locus was found strongly associated with VTE. However, using this large cohort of subjects, we were able to replicate the mild effects of 2 nonsynonymous SNPs, rs1613662 in GP6 and rs13146272 in CYP4V2, recently suspected to be associated with VTE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278955     DOI: 10.1182/blood-2008-11-190389

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  114 in total

1.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.

Authors:  Weihong Tang; Christine Schwienbacher; Lorna M Lopez; Yoav Ben-Shlomo; Tiphaine Oudot-Mellakh; Andrew D Johnson; Nilesh J Samani; Saonli Basu; Martin Gögele; Gail Davies; Gordon D O Lowe; David-Alexandre Tregouet; Adrian Tan; James S Pankow; Albert Tenesa; Daniel Levy; Claudia B Volpato; Ann Rumley; Alan J Gow; Cosetta Minelli; John W G Yarnell; David J Porteous; John M Starr; John Gallacher; Eric Boerwinkle; Peter M Visscher; Peter P Pramstaller; Mary Cushman; Valur Emilsson; Andrew S Plump; Nena Matijevic; Pierre-Emmanuel Morange; Ian J Deary; Andrew A Hicks; Aaron R Folsom
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

Review 2.  Genetics of atherothrombosis and thrombophilia.

Authors:  Anders Mälarstig; Anders Hamsten
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

Review 3.  Genomics and epigenomics of the human glycome.

Authors:  Vlatka Zoldoš; Mislav Novokmet; Ivona Bečeheli; Gordan Lauc
Journal:  Glycoconj J       Date:  2012-05-31       Impact factor: 2.916

4.  Race, ABO blood group, and venous thromboembolism risk: not black and white.

Authors:  Chunhui Fang; Hillel W Cohen; Henny H Billett
Journal:  Transfusion       Date:  2012-04-27       Impact factor: 3.157

5.  A1B and BB blood group genotypes are risk factors for pulmonary embolism.

Authors:  Tatjana Kereš; Irena Jukić; Tomo Svaguša; Ingrid Prkačin; Jasna Bingulac-Popović; Matea Vinković; Ana Hećimović; Marcela Živković; Nikolina Parašilovac
Journal:  Wien Klin Wochenschr       Date:  2021-06-03       Impact factor: 1.704

6.  Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Authors:  Brian M Wolpin; Peter Kraft; Mousheng Xu; Emily Steplowski; Martin L Olsson; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Rachael Z Stolzenberg-Solomon; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Melissa A Austin; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Stephen J Chanock; J Michael Gaziano; Edward L Giovannucci; Göran Hallmans; Susan E Hankinson; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Charles Kooperberg; Julie B Mendelsohn; Dominique S Michaud; Kim Overvad; Alpa V Patel; Maria-José Sanchéz; Leah Sansbury; Xiao-Ou Shu; Nadia Slimani; Geoffrey S Tobias; Dimitrios Trichopoulos; Paolo Vineis; Kala Visvanathan; Jarmo Virtamo; Jean Wactawski-Wende; Joanne Watters; Kai Yu; Anne Zeleniuch-Jacquotte; Patricia Hartge; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-22       Impact factor: 4.254

7.  ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis.

Authors:  John P Reilly; Nuala J Meyer; Michael G S Shashaty; Rui Feng; Paul N Lanken; Robert Gallop; Sandra Kaplan; Maximilian Herlim; Nathaniel L Oz; Isabel Hiciano; Ana Campbell; Daniel N Holena; Muredach P Reilly; Jason D Christie
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

8.  Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Aaron R Folsom; Weihong Tang; Kristen M George; Susan R Heckbert; Richard F MacLehose; Mary Cushman; James S Pankow
Journal:  Thromb Res       Date:  2016-01-12       Impact factor: 3.944

9.  A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.

Authors:  Weihong Tang; Martina Teichert; Daniel I Chasman; John A Heit; Pierre-Emmanuel Morange; Guo Li; Bruno H Ch Stricker; Paul M Ridker; Aaron R Folsom; Nicholas L Smith; Nathan Pankratz; Frank W Leebeek; Guillaume Paré; Mariza de Andrade; Christophe Tzourio; Bruce M Psaty; Saonli Basu; Rikje Ruiter; Lynda Rose; Sebastian M Armasu; Thomas Lumley; Susan R Heckbert; André G Uitterlinden; Mark Lathrop; Kenneth M Rice; Mary Cushman; Albert Hofman; Jean-Charles Lambert; Nicole L Glazer; James S Pankow; Jacqueline C Witteman; Philippe Amouyel; Joshua C Bis; Edwin G Bovill; Xiaoxiao Kong; Russell P Tracy; Eric Boerwinkle; Jerome I Rotter; David-Alexandre Trégouët; Daan W Loth
Journal:  Genet Epidemiol       Date:  2013-05-05       Impact factor: 2.135

10.  Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).

Authors:  Marie Méan; Drahomir Aujesky; Bernhard Lämmle; Christiane Gerschheimer; Sven Trelle; Anne Angelillo-Scherrer
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.